ECMscaffolds

ECM scaffolds, or extracellular matrix scaffolds, are biomaterials designed to mimic the native extracellular matrix of tissues to support cell adhesion, proliferation, and differentiation during repair and regeneration. They are typically derived from natural extracellular matrix by decellularizing donor tissues or organs, yielding a scaffold that retains native architecture, biochemical cues, and mechanical properties. ECM scaffolds can also be produced from defined ECM components such as collagen, laminin, elastin, and glycosaminoglycans, assembled into hydrogels, sheets, or three-dimensional matrices.

Decellularization removes cellular components while attempting to preserve ECM structure. The resulting scaffolds can be used acellularly or repopulated with autologous or allogeneic cells. They can be processed into whole-tissue scaffolds, powder, hydrogels, or composite materials, with crosslinking or chemical modification used to adjust stiffness and degradation rates. Sterilization and storage are critical considerations to maintain bioactivity.

ECM scaffolds support host cell infiltration, vascularization, and tissue remodeling, and have been explored for cardiovascular, musculoskeletal, skin, neural, and organ regeneration, as well as wound healing and drug delivery. They often provide preserved growth factors and signaling cues that guide regeneration and reduce immune reaction when properly prepared.

Limitations include batch variability, potential residual antigens, risk of immune reaction, mechanical inadequacy for load-bearing applications, difficulty achieving complete sterilization without damaging bioactivity, and high processing costs. Ongoing work aims to standardize decellularization, improve mechanical properties, and develop synthetic–ECM hybrids that combine bioactivity with tunable strength.